US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

HEALIOS K K

3.17

0.0000

Volume:- -

Turnover:- -

Market Cap:321.00M

PE:-6.34

High:3.17

Open:3.17

Low:3.17

Close:3.17

Loading ...

Overview Company News Filings

Company Profile

Company Name:

HEALIOS K K

Exchange:

PINK LIMITED

Establishment Date:

2011

Employees:

65

Office Location:

Hibiya Mitsui Tower, WORK STYLING,12 floor,1-1-2 Yurakucho,Chiyoda-ku,Tokyo,Japan

Website:

http://www.healios.co.jp

Zip Code:

100-0006

Phone:

- -

Fax:

- -

Introduction:

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HLOSF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HLOSF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLOSF\",,,,,undefined,":{"symbol":"HLOSF","market":"US","secType":"STK","nameCN":"HEALIOS K K","latestPrice":3.17,"timestamp":1749067200000,"preClose":3.17,"halted":0,"volume":0,"delay":15,"floatShares":40607331,"shares":101261302,"eps":-0.499689,"marketStatus":"Closed","change":0,"latestTime":"06-04 16:00:00 EDT Delay","open":3.17,"high":3.17,"low":3.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.499689,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749110400000},"marketStatusCode":5,"adr":0,"exchange":"PINK LIMITED","adjPreClose":3.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLOSF\",,,,,undefined,":{"symbol":"HLOSF","floatShares":40607331,"roa":"-9.88%","roe":"-153.60%","lyrEps":-0.39881,"shares":101261302,"dividePrice":0,"high":3.17,"amplitude":0,"preClose":3.17,"low":3.17,"week52Low":0.96,"pbRate":"23.43","psRate":"77.91","week52High":3.17,"institutionHeld":0,"latestPrice":3.17,"eps":-0.499689,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.499689,"open":3.17,"prevYearClose":1.35,"prevWeekClose":3.17,"prevMonthClose":3.17,"prevQuarterClose":1.94,"fiveDayClose":2.25,"twentyDayClose":2.25,"sixtyDayClose":1.94},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":233918548,"yearFounded":2011,"employeeNum":65,"address":"Hibiya Mitsui Tower, WORK STYLING,12 floor,1-1-2 Yurakucho,Chiyoda-ku,Tokyo,Japan","zipCode":"100-0006"},"stockCompanyDetail":{"websiteUrl":"http://www.healios.co.jp","description":"Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.","exchange":"PINK LIMITED","name":"HEALIOS K K","nameEN":"HEALIOS K K"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"HLOSF\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLOSF\",params:#limit:5,,,undefined,":[{"date":"2024-05-13","symbol":"HLOSF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715587200000,"name":null,"time":"","dateTimestamp":1715572800000,"actualEps":null},{"market":"US","date":"2023-11-14","symbol":"HLOSF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"","actualEps":null},{"date":"2023-08-14","symbol":"HLOSF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692000000000,"name":null,"time":"","dateTimestamp":1691985600000,"actualEps":null},{"date":"2022-11-14","symbol":"HLOSF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668416400000,"name":null,"time":"Pre-Market","dateTimestamp":1668402000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLOSF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HLOSF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1725940800000}}}